Review: Hepatitis C virus,autoimmunity and rheumatic disease

Abstract

Get full access to this article

View all access options for this article.

References

Choo QL et al. Isolation of cDNA clone derived from blood-born non-A, non-B viral hepatitis genome. Science 1989; 244: 359—362.

Kuo G. et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989 ; 244: 362-364.

Alter HJ et al. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med 1992; 327: 1899-1905.

Simmonds P. Clinical relevance of hepatitis C virus genotypes. Gut 1997; 40: 291-293.

Shimizu YK et al. Neutralizing antibodies against hepatitis C virus and the emergence of neutralizing escape mutant viruses. J Virol 1994; 68: 1494—1500.

Bukh J. , Miller RH , Purcell RH Genetic heterogenity of hepatitis C virus: quasispecies and genotypes . Semin Liver Dis 1995; 15: 41-63.

Enomoto N. , Sato C. Clinical relevance of hepatitis C virus quasispecies. J Viral Hepat 1995; 2: 267-272.

Agnello V. , Romain PL Mixed cryoglobulinemia secondary to hepatitis C virus infection. Rheum Dis Clin North Am 1996; 22: 1—21.

Monzahian M. , Home B. , Thomssen R. Binding of human lipoprotein to the E1/E2 protein of the hepatitis C virus . In Abstracts of 2nd International Meeting on Hepatitis C related Viruses, 31 July 5 August, University of California , San Diego Publication, 1994, p.22.

10.

Dusheiko GM , Khakoo S. , Soni P. , Grellier L. A rational approach to the managment of hepatitis C infection. Br Med J 1996; 312: 357-364.

11.

Colombo M. Hepatocellular carcinoma. J Hepatol 1992; 15: 225-236.

12.

Ferri C. et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma . Br J Haematol 1994; 88: 392—394.

13.

Sikuler E. et al. Hepatitis C virus infection and extrahepatic malignancies. J Clin Gastroenterol 1997; 24: 87—89.

14.

Wener MH , Johnson RJ , Sasso EH , Gretch DR Hepatitis C virus and rheumatic disease. J Rheumatol 1996; 23: 953—959.

15.

Hadziyannis SJ The spectrum of extrahepatic manifestations in hepatitis C virus infection. J Viral Hepatitis 1997; 4. 9—28.

16.

Martin P. Hepatitis C: more than just a liver disease, Gastroenterology 1993; 104: 320-323.

17.

Gumber SC , Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations . Ann Intern Med 1995; 123: 615-620.

18.

Clifford BD et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995; 21: 613-619.

19.

Ferri C. et al. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia . Arthritis Rheum 1991; 34: 1606-1610.

20.

Agnello V. , Chung RT , Kaplan LM A role for hepatitis C virus infection in type II cryoglobulinemia . N Engl J Med 1992; 327: 1490-1495.

21.

Cacoub P. et al. Mixed cryoglobulinemia and hepatitis c virus. Am J Med 1994; 96: 124—132.

22.

Haddad J. et al. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 1992; 339: 321-323.

23.

Mariette X. et al. Hepatitis C virus and Sjögren's syndrome . Arthritis Rheum 1993; 36: 280-281.

24.

Siegel LB , Cohn L. , Nashel D. Rheumatic manifestations of hepatitis C infection. Sem Arthritis Rheum 1993; 23: 149—154.

25.

Lovy MR , Starkebaum G. , Uberoi S. Hepatitis C infection presenting with rhrumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 1996; 23: 979—983.

26.

Strassburg CP , Manns MP Autoimmune hepatitis versus viral hepatitis C. Liver 1995; 15: 225—232.

27.

Scheuer PJ , Ashrafzadeh P. , Sherlock S. , Brown D. , Dusheiko GM The pathology of hepatitis C. Hepatology 1992 ; 15: 567-571.

28.

Alberti A. et al. Hepatitis C viremia and liver disease in symptom free individuals with anti-HCV. Lancet 1992; 340: 677-698.

29.

Rice CM , Walker CM Hepatitis C virus-specific T lymphocyte responses. Curr Opini Immunol 1995; 7: 532—538.

30.

Koziel MJ et al. Hepatitis C virus (HCV) specific cytotoxic T lymphocytes recognize epitopes in the core and envelop proteins of HCV. J Virol 1993; 67: 7522-7532.

31.

Shirai M. et al. An epitope in hepatitis C virus core region recognized by cytotoxic T cells in mice and humans. J Virol 1994; 68: 3334-3342.

32.

Cerny A. et al. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest 1995; 95: 521-530.

33.

Chu CM , Liaw YF Coexpression of intercellular adhesion molecule 1 and class I major histocompatibilty complex antigens on hepatocyte membrane in chronic viral hepatitis. J Clin Pathol 1993; 46: 1004-1008.

34.

Mosnier JF et al. Expression of cytokine-dependent immune adhesion molecules by hepatocyte and bile duct cells in chronic hepatitis C Gastroenterology 1994; 1107: 1457-1468.

35.

Liaw YF et al. T-cell mediated autologous hepatocytotoxicity in patients with chronic hepatitis C virus infection. Hepatology 1995; 22: 1368-1373.

36.

Garyfallos A. et al. Interleukin 2-dependent immunoregulatory function in hemodialysis patients with chronic hepatitis C. J Investig Allergol Clin Immunol 1995; 5: 255-258.

37.

Fukuda R. et al. Expression rate of cytokine mRNA in the liver of chronic hepatitis C: Comparison with hepatitis B. J Gastroenterol 1955; 30: 41-47.

38.

Jirillo E. et al. Evaluation of cellular immune responses and soluble mediators in patients with chronic hepatitis C virus infection. Immunopharmacol Immunotoxicol 1995; 17: 347-364.

39.

Czaja AJ , Carpenter HA , Santrach PJ , Moore SB Significance of human leukocyte antigens DR3 and DR4 in chronic viral hepatitis . Dig Dis Sci 1995; 40: 2098—2106.

40.

Pawlotsky JM et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1955; 122: 169—173.

41.

Richardet JP et al. Prevalence and characteristics of anti-tissue antibodies in chronic hepatitis caused by hepatitis C virus. Gastroenterol Clin Biol 1994; 18: 819—823.

42.

Mishiro S. et al. Non-A, non-B hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet 1990; 336: 1400-1403.

43.

Michel G. et al. Anti-GOR and hepatitis C virus in autoimmune liver diseases . Lancet 1992; 339: 267-269.

44.

Czaja AJ Manns MP The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 1995; 90: 1206-1211.

45.

Prieto J. et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology 1996; 23: 199-204.

46.

Tran A. et al. High prevalence of thyroid autoantibodies in a prospective sereies of patients with chronic hepatitis C before interferon therapy. Hepatology 1993; 18: 253—257.

47.

Parke AL , Parke DV Hepatic disease, the gastrointestinal tract, and rheumatic disease . Curr Opin Rhumatol 1994; 6: 85—94.

48.

Hartmann H. , Schott P. , Polzien F. , Mihm S. , Ramadori G. Cryoglobulinemias in chronic hepatitis C virus infection: is cross-reactivity of anti-HCV IgM to IgG a pathogenetic mechanism? J Hepatol 1995; 25: (Suppl.1): WP1/05 (abstract).

49.

Bon E. et al. Rheumatic manifestations of chronic hepatitis C and response to the treatment with interferon alpha- 2b (French). Rev Rheum Ed Fr 1994; 61: 497-504.

50.

Harada M. et al. Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases. Int Hepatol Commun 1995; 4: 195-200.

51.

Weidensaul D. , Imam T. , Holyst MM , King PD , NcMurray RW Polymyosistis, pulmonary fibrosis and hepatitis C. Arthritis Rheum 1995; 38: 437-439.

52.

Gorevic PD et al. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980; 69: 287-308.

53.

Pawlotsky JM et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841-848.

54.

Quint L. et al. Hepatitis C virus in patients with polyarteritis nodosa. Prevalence in 38 patients. Clin Exp Rheumatol 1991; 9: 253-257.

55.

Cacoub P. , Lunel-Fabiani F. , Du LT Polyarteritis nodosa and hepatitis C virus infection. Ann Intern Med 1992; 116: 605-606.

56.

Carson CW , Conn DL , Czaja AJ , Wright TL , Brecher ME Frequency and significance of antibodies to hepatitis C virus in polyarteritis nodosa. J Rheumatol 1993; 20: 304—309.

57.

Kimura Y. , Kajiyama K. , Nomura H. , Shiraishi G. Severe thrombocytopenia during interferon-alpha therapy for chronic active hepatitis C associated with systemic lupus erythematosus. (Japanese) . Fukuoka Igaku Zasshi 1994; 85: 329-333.

58.

Sanchez RJ , Castillo Palma MJ, Garcia Diaz E, Ferrer Ordinez JA. Systemic lupus erythematosus induced by recombinant alpha interferon treatment. (Spanish) . Med Clin (Barc) 1994; 102: 198.

59.

Abu-Shakra et al. Hepatitis B and C viruses serology in patients with SLE. Lupus 1997; 6: 543-544.

60.

Moder KG , Lindor K. Muskuloskeletal symptoms associated with hepatitis C. Arthritis Rheum 1995; 38 (Suppl): 284 (abstract).

61.

Garcia-Monforte A. , Romero M. , de Diego A. , Rivera J. Rheumatic and autoimmune manifestations in chronic hepatitis C virus infection. Arthritis Rheum 1995; 38 (Suppl): 286 (abstract).

62.

Zingego AL et al. Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996 ; 124: 31-34.

63.

Buskila D. et al. Fibromyalgia in hepatitis C virus infection: another infectious disease relationship. Arch Intern Med (in press).

64.

Abu-Shakra M. , Shoenfeld Y. Chronic infection and autoimmunity . Immunol Ser 1992; 55: 285—313.

65.

Haflon P. et al. Myasthenia gravis and hepatitis C virus infection. Hepatology 1995; 22: 425A (abstract).